These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6270087)

  • 1. Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets.
    Plow EF; Ginsberg MH
    J Biol Chem; 1981 Sep; 256(18):9477-82. PubMed ID: 6270087
    [No Abstract]   [Full Text] [Related]  

  • 2. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation characteristics of platelets in stored concentrates of human blood.
    Nolan ML; Harrington MG
    Biochem Soc Trans; 1995 May; 23(2):373S. PubMed ID: 7672404
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of platelets and concanavalin A.
    Kaplan KL; Nachman RL
    Thromb Res; 1975 Dec; 7(6):847-59. PubMed ID: 1198553
    [No Abstract]   [Full Text] [Related]  

  • 12. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphorylation and diglyceride production during serotonin release induced by epinephrine plus ADP in human platelets.
    Kawahara Y; Yamanishi J; Tsunemitsu M; Fukuzaki H
    Thromb Res; 1983 Jun; 30(5):477-85. PubMed ID: 6612681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
    Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
    Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation and wheat germ agglutinin-binding.
    Rotman A; Heldman J
    FEBS Lett; 1980 Feb; 110(2):330-2. PubMed ID: 6892804
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of nicotine on platelets.
    Saba SR; Mason RG
    Thromb Res; 1975 Nov; 7(5):819-24. PubMed ID: 1209564
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
    Sweatt JD; Johnson SL; Cragoe EJ; Limbird LE
    J Biol Chem; 1985 Oct; 260(24):12910-9. PubMed ID: 2997148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
    Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
    Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of fibronectin to alpha-granule-deficient platelets.
    Ginsberg MH; Wencel JD; White JG; Plow EF
    J Cell Biol; 1983 Aug; 97(2):571-3. PubMed ID: 6309863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.